NCT05949320Completed
"Health in Mobile" for Community-dwelling Individuals With Chronic Diseases
"Health in Mobile" - The e-Motivational-Interviewing Intervention for Community-dwelling Individuals With Chronic Diseases
Source: ClinicalTrials.gov · Last updated 22 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to provide a mobile-apps-based intervention to facilitate individuals with chronic diseases such as high blood pressure and diabetes to adopt healthy behaviours. The intervention is based on Motivational Interviewing, a clinical technique used to enhance an individual's behavioural changes. The proposed research project comprises developing and validating the "Health in Mobile" app, which we call e-MI, which will then be launched to members of the three District Health Centre Express (DCHEs) who have presented with clinical/preclinical chronic health issues such as high blood pressure and diabetes. The participants are registered members of the three DCHEs. The targeted sample size is 1600 members, with 1200 are in the e-MI group while the other 400 are in the waiting list control group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 461 (actual)
- First submitted
- 29 Jun 2023
- Start date
- 3 Apr 2023
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Education University of Hong Kong
- Diseases
- High blood pressure
- NCT number
- NCT05949320
What you commit to
- Study type: Interventional
- Participants enrolled: 461
- From 3 Apr 2023 to the primary completion date, 30 Sept 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 2\) clinical diagnosis of cardiovascular disease, kidney disease, liver disease, malignant tumour, or new-onset diabetes after organ transplant;
- 3\) participants with a psychiatric or neurological disability
Lab values
- 1\) participants with type 1 diabetes, impaired glucose tolerance, metabolic syndrome, maturity-onset diabetes of youth, or gestational diabetes;
Who the study is looking for
- 1\) pass the cognitive screening test indicating low risk of mild cognitive impairment and depressive moods;
- 2\) age 45 to 75 years;
- 3\) completed primary school education or above;
- 4\) has a considerate level of information literacy access to mobile phones and tablets;
- 5\) agree to participate in the study and provide informed consent.
Age in the registry: 45 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eastern District Health Centre Express Coordinator of this site? Confirm its status | North Point | Hong Kong SAR China | Unknown status |
| Central and Western District Health Centre Express Coordinator of this site? Confirm its status | Sai Ying Pun | Hong Kong SAR China | Unknown status |
| Sha Tin District Health Centre Express Coordinator of this site? Confirm its status | Shatin | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.